Maharashtra
News Category

Okogen Doses First Patient in EMERALD Trial, Advancing Treyegen Toward a New Treatment Approach for Acute Infectious Conjunctivitis
Okogen has dosed the first patient in its Phase 1/2 EMERALD trial of Treyegen for acute infectious conjunctivitis, a milestone that could validate its...
November 2, 2026Read the full article →


